You are not logged in (login)

Research Center

JOBS

List >

PHONEBOOK

Sylvie Trottier

Formation
MD

MSc

FRCPC

No active offer

All active job offers
Principal area
Infectious and immune diseases
Address
Centre Hospitalier de l'Université Laval (CHUL)
2705, boulevard Laurier, RC-709
Québec (Québec)
CANADA G1V 4G2

Phone
+1 418-525-4444, poste 42705
Fax
+1 418-654-2715
Email
sylvie.trottier@crchudequebec.ulaval.ca

Recent publications (see all publication from this researcher)

Omar RF, Trottier S, Brousseau G, Ouellet C, Danylo A, Ong T, Bergeron MG. Universal vaginal applicator for the uniform distribution of vaginal gel and cream formulations: a magnetic resonance imaging study. Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC,  2014. 36: 42-50
Zetterberg E, Neuhaus J, Baker JV, Somboonwit C, Llibre JM, Palfreeman A, Chini M, Lundgren JD, INSIGHT SMART Study Group. Platelet count kinetics following interruption of antiretroviral treatment. AIDS (London, England) ,  2013. 27: 59-68
Blitz S, Baxter J, Raboud J, Walmsley S, Rachlis A, Smaill F, Ferenczy A, Coutlee F, Hankins C, Money D, Canadian Women's HIV Study Group. Evaluation of HIV and highly active antiretroviral therapy on the natural history of human papillomavirus infection and cervical cytopathologic findings in HIV-positive and high-risk HIV-negative women. The Journal of infectious diseases,  2013. 208: 454-62
Bjerk SM, Baker JV, Emery S, Neuhaus J, Angus B, Gordin FM, Pett SL, Stephan C, Kunisaki KM, INSIGHT SMART Study Group. Biomarkers and bacterial pneumonia risk in patients with treated HIV infection: a case-control study. PLoS ONE,  2013. 8: e56249
Longtin Y, Trottier S, Brochu G, Paquet-Bolduc B, Garenc C, Loungnarath V, Beaulieu C, Goulet D, Longtin J. Impact of the type of diagnostic assay on Clostridium difficile infection and complication rates in a mandatory reporting program. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,  2013. 56: 67-73
Loutfy MR, Walmsley SL, Klein MB, Raboud J, Tseng AL, Blitz SL, Pick N, Conway B, Angel JB, Rachlis AR, Gough K, Cohen J, Haase D, Burdge D, Smaill FM, de Pokomandy A, Loemba H, Trottier S, la Porte CJ. Factors affecting antiretroviral pharmacokinetics in HIV-infected women with virologic suppression on combination antiretroviral therapy: a cross-sectional study. BMC infectious diseases,  2013. 13: 256
Rodrigues-Coutlee C, Archambault J, Money D, Ramanakumar AV, Raboud J, Hankins C, Koushik A, Richardson H, Brassard P, Franco EL, Coutlee F, Canadian Women's HIV Study Group. Human papillomavirus type 56 polymorphism in Canadian women with and without cervical lesions. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology,  2013. 58: 660-5
Routy JP, Angel JB, Spaans JN, Trottier B, Rouleau D, Baril JG, Harris M, Trottier S, Singer J, Chomont N, Sekaly RP, Tremblay CL. Design and Implementation of a Randomized Crossover Study of Valproic Acid and Antiretroviral Therapy to Reduce the HIV Reservoir. HIV clinical trials,  2012. 13: 301-7
Routy J, Tremblay C, Angel J, Trottier B, Rouleau D, Baril J, Harris M, Trottier S, Singer J, Chomont N, Sekaly R, Boulassel M. Valproic acid in association with highly active antiretroviral therapy for reducing systemic HIV-1 reservoirs: results from a multicentre randomized clinical study. HIV medicine,  2012. 13: 291-6
Cornut G, Gagnon S, Hankins C, Money D, Pourreaux K, Franco EL, Coutlee F, Canadian Women's HIV Study Group. Polymorphism of the capsid L1 gene of human papillomavirus types 31, 33, and 35. Journal of medical virology,  2010. 82: 1168-78
© 2014 All rights reserved CRCHU de Québec